BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30869486)

  • 1. Measurement of the incidence of care-associated adverse events at the Department of Pediatrics of a teaching hospital.
    Fajreldines A; Schnitzler E; Torres S; Panattieri N; Pellizzari M
    Arch Argent Pediatr; 2019 Apr; 117(2):e106-e109. PubMed ID: 30869486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics associated with the occurrence of adverse events: a retrospective medical record review using the Global Trigger Tool in a fully digitalized tertiary teaching hospital in Korea.
    Hwang JI; Chin HJ; Chang YS
    J Eval Clin Pract; 2014 Feb; 20(1):27-35. PubMed ID: 23890097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the Global Trigger Tool method.
    Härkänen M; Kervinen M; Ahonen J; Voutilainen A; Turunen H; Vehviläinen-Julkunen K
    J Clin Nurs; 2015 Feb; 24(3-4):582-91. PubMed ID: 25393838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is researching adverse events in hospital deaths a good way to describe patient safety in hospitals: a retrospective patient record review study.
    Baines RJ; Langelaan M; de Bruijne MC; Wagner C
    BMJ Open; 2015 Jul; 5(7):e007380. PubMed ID: 26159451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of adverse events detected in a large health care delivery system using an enhanced global trigger tool over a five-year interval.
    Kennerly DA; Kudyakov R; da Graca B; Saldaña M; Compton J; Nicewander D; Gilder R
    Health Serv Res; 2014 Oct; 49(5):1407-25. PubMed ID: 24628436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia.
    Dedefo MG; Mitike AH; Angamo MT
    BMC Pediatr; 2016 Jul; 16():81. PubMed ID: 27387547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an electronic trigger tool at a children's hospital within an academic medical center.
    Fortenberry M; Odinet J; Shah P; McKinzie C; Murphy K; Faircloth CB; Falato C; Pappas A
    Am J Health Syst Pharm; 2019 Nov; 76(Supplement_4):S107-S113. PubMed ID: 31724037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of triggers and development of a pediatric trigger tool to identify adverse events.
    Unbeck M; Lindemalm S; Nydert P; Ygge BM; Nylén U; Berglund C; Härenstam KP
    BMC Health Serv Res; 2014 Dec; 14():655. PubMed ID: 25527905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent-Reported Errors and Adverse Events in Hospitalized Children.
    Khan A; Furtak SL; Melvin P; Rogers JE; Schuster MA; Landrigan CP
    JAMA Pediatr; 2016 Apr; 170(4):e154608. PubMed ID: 26928413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs.
    Sharek PJ; Horbar JD; Mason W; Bisarya H; Thurm CW; Suresh G; Gray JE; Edwards WH; Goldmann D; Classen D
    Pediatrics; 2006 Oct; 118(4):1332-40. PubMed ID: 17015521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient safety and adverse events related with obstetric care.
    Aibar L; Rabanaque MJ; Aibar C; Aranaz JM; Mozas J
    Arch Gynecol Obstet; 2015 Apr; 291(4):825-30. PubMed ID: 25245667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigating risk in Norwegian psychiatric care: Identifying triggers of adverse events through Global Trigger Tool for psychiatric care.
    Okkenhaug A; Tritter JQ; Myklebust TÅ; Deilkås ET; Meirik K; Landstad BJ
    Int J Risk Saf Med; 2019; 30(4):203-216. PubMed ID: 31561389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Events and Patient Outcomes Among Hospitalized Children Cared for by General Pediatricians vs Hospitalists.
    Atkinson MK; Schuster MA; Feng JY; Akinola T; Clark KL; Sommers BD
    JAMA Netw Open; 2018 Dec; 1(8):e185658. PubMed ID: 30646280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Trigger Tool to Identify Adverse Events and Harm in a Neuropsychiatry Setting.
    Sharma S; Kapoor K; Nasare N; Bhardhwaj A; Kushwaha S
    J Patient Saf; 2022 Jan; 18(1):e343-e350. PubMed ID: 34951611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.
    Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T
    BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a pediatric trigger tool based on Global Trigger Tool to identify adverse drug events of children: experience in a Chinese hospital.
    Liu Y; Yan J; Xie Y; Bian Y
    BMC Pediatr; 2020 Sep; 20(1):454. PubMed ID: 32993580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands.
    Hoonhout LH; de Bruijne MC; Wagner C; Asscheman H; van der Wal G; van Tulder MW
    Drug Saf; 2010 Oct; 33(10):853-64. PubMed ID: 20812770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.